Products

Paclitax Nab 100mg Injection (Nab-Paclitaxel) – Global Supplier & Exporter | Ernest Oncology Paclitax Nab 100mg Injection Paclitax Nab 100mg Injection contains Nab-Paclitaxel (Albumin-bound Paclitaxel), a chemotherapy medicine widely used in the treatment of breast cancer, lung cancer, and pancreatic cancer. This advanced formulation improves drug delivery to tumors while reducing certain side effects associated with conventional paclitaxel therapy. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Paclitax Nab 100mg injections to hospitals, oncology centers, pharmaceutical distributors, and international wholesalers worldwide. What is Paclitax Nab 100mg Injection? Paclitax Nab 100mg Injection is a chemotherapy medicine used in cancer treatment. The active ingredient Nab-Paclitaxel is a protein-bound formulation of paclitaxel that enhances drug transport into cancer cells and improves treatment effectiveness. This formulation helps deliver higher concentrations of the drug directly to tumor tissues. Mechanism of Action Nab-Paclitaxel works by interfering with the microtubule structures inside cancer cells. Its mechanism includes: • Stabilizing microtubules and preventing cell division • Blocking cancer cell replication • Inducing apoptosis (programmed cancer cell death) • Slowing tumor growth and spread This helps stop the multiplication of rapidly dividing cancer cells. Indications Paclitax Nab 100mg Injection is used for the treatment of: • Metastatic Breast Cancer • Non-Small Cell Lung Cancer (NSCLC) • Pancreatic Cancer It may be used alone or in combination with other chemotherapy medicines. Dosage & Administration Typical dosage guidelines: • Administered as intravenous infusion • Dosage depends on patient body surface area and treatment plan • Usually given in cycles as prescribed by an oncologist Treatment should be administered under medical supervision in a clinical setting. Key Benefits of Paclitax Nab 100mg Injection ✔ Advanced albumin-bound paclitaxel chemotherapy formulation ✔ Improved drug delivery to tumor cells ✔ Effective treatment for multiple cancers ✔ Reduced solvent-related toxicity compared to traditional paclitaxel ✔ Widely used in modern oncology treatment protocols Possible Side Effects Some patients may experience: • Fatigue • Hair loss • Nausea • Peripheral neuropathy • Low blood cell counts • Weakness Patients should be monitored regularly during treatment. Product Specifications Product Name: Paclitax Nab Generic Name: Nab-Paclitaxel Strength: 100 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Antimicrotubule Chemotherapy Agent Packaging: Vial Storage: Store below 25°C Ernest Oncology supplies Paclitax Nab 100mg injections worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Lenalid 25mg (Lenalidomide) Capsule – Global Supplier & Exporter | Ernest Oncology Lenalid 25mg Lenalidomide Capsules – Advanced Therapy for Multiple Myeloma & Blood Cancers Lenalid 25mg Capsule (Lenalidomide) is a powerful immunomodulatory anti-cancer medicine widely used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and other hematological malignancies. Lenalidomide helps the immune system attack cancer cells and slows down abnormal cell growth in the bone marrow. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Lenalid 25mg (Lenalidomide) Capsules to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Lenalid 25mg (Lenalidomide) Capsule? Lenalid 25mg contains Lenalidomide, an immunomodulatory drug (IMiD) derived from thalidomide. It modifies immune system activity and inhibits the growth of malignant plasma cells responsible for blood cancers. Lenalidomide has become one of the most important therapies in modern hematology and oncology treatment protocols worldwide, particularly for multiple myeloma patients. Mechanism of Action Lenalidomide works through several anti-cancer mechanisms: • Stimulates immune cells to attack cancer cells • Inhibits angiogenesis (formation of blood vessels feeding tumors) • Reduces abnormal plasma cell growth in bone marrow • Induces apoptosis (programmed cancer cell death) These mechanisms make Lenalidomide a highly effective targeted immunomodulatory therapy for blood cancers. Medical Uses of Lenalid 25mg Capsule Doctors prescribe Lenalid (Lenalidomide) for several hematologic malignancies: Multiple Myeloma Used in combination with dexamethasone and other chemotherapy drugs to treat multiple myeloma. Myelodysplastic Syndromes (MDS) Helps manage anemia associated with MDS, particularly in patients with chromosome abnormalities. Mantle Cell Lymphoma Used in the treatment of relapsed or refractory mantle cell lymphoma. Maintenance Therapy Often prescribed as maintenance therapy after stem cell transplantation to prevent relapse. Benefits of Lenalid 25mg (Lenalidomide) Capsule • Advanced immunomodulatory anti-cancer therapy • Effective treatment for multiple myeloma • Boosts immune system to fight cancer cells • Oral capsule therapy for convenient treatment • Recommended in global oncology treatment guidelines Product Information Product Name: Lenalid Capsule Generic Name: Lenalidomide Strength: 25 mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / Immunomodulatory Agent Indication: Multiple Myeloma, MDS, Mantle Cell Lymphoma Prescription: Required Global Demand for Lenalidomide Capsules With the rising incidence of multiple myeloma and other blood cancers worldwide, demand for Lenalidomide therapy medicines continues to increase. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Lenalidomide capsules from reliable pharmaceutical exporters in India, such as Ernest Oncology. Lenalid 25mg Capsule Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries •GMP compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Vivitra 440mg Injection (Trastuzumab) – Global Supplier & Exporter | Ernest Oncology Vivitra 440mg Injection Vivitra 440mg Injection contains Trastuzumab, a targeted monoclonal antibody therapy used in the treatment of HER2-positive breast cancer and gastric cancer. It works by specifically targeting the HER2 (Human Epidermal Growth Factor Receptor 2) protein on cancer cells, helping to stop tumor growth and spread. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Vivitra 440mg injections to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What is Vivitra 440mg Injection? Vivitra Injection is a biological targeted therapy medicine designed for patients with HER2-positive cancers. The active ingredient Trastuzumab binds to HER2 receptors on cancer cells and blocks signals that promote tumor growth. This targeted approach helps slow cancer progression and improves treatment outcomes. Mechanism of Action Trastuzumab works by targeting the HER2 receptor protein found on certain cancer cells. Its mechanism includes: • Binding to HER2 receptors on cancer cells • Blocking growth signals that stimulate tumor cells • Activating immune response against cancer cells • Preventing cancer cell proliferation This targeted therapy helps reduce tumor growth and improve survival rates. Indications Vivitra 440mg Injection is used for the treatment of: • HER2-Positive Breast Cancer • Metastatic Breast Cancer • HER2-Positive Gastric Cancer • Advanced Stomach Cancer It may be used alone or in combination with chemotherapy medicines. Dosage & Administration Typical dosage guidelines: • Administered as intravenous infusion • Initial loading dose followed by maintenance doses • Dosage depends on patient body weight and treatment protocol Treatment should be administered under the supervision of a qualified oncologist. Key Benefits of Vivitra 440mg Injection ✔ Targeted therapy for HER2-positive cancers ✔ Helps slow tumor growth and progression ✔ Improves survival outcomes in breast cancer patients ✔ Effective monoclonal antibody therapy ✔ Can be combined with chemotherapy for enhanced treatment Possible Side Effects Some patients may experience: • Infusion reactions • Fever or chills • Fatigue • Nausea • Headache • Shortness of breath Patients should be monitored during treatment. Product Specifications Product Name: Vivitra Generic Name: Trastuzumab Strength: 440 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Monoclonal Antibody Packaging: Vial Storage: Store in refrigerator (2°C – 8°C) Ernest Oncology supplies Vivitra 440mg injections worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ WHO-GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Lenalid 15mg (Lenalidomide) Capsule – Global Supplier & Exporter | Ernest Oncology Lenalid 15mg Lenalidomide Capsules – Advanced Therapy for Multiple Myeloma & Blood Cancers Lenalid 15mg Capsule (Lenalidomide) is a powerful immunomodulatory anti-cancer medicine used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and other hematologic cancers. Lenalidomide enhances the body’s immune response and helps inhibit the growth of cancer cells. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Lenalid 15mg (Lenalidomide) Capsules to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica.What is Lenalid 15 mg (Lenalidomide) capsule? Lenalid 15mg contains Lenalidomide, an immunomodulatory drug (IMiD) derived from thalidomide. It works by modifying immune system responses and suppressing abnormal cancer cell growth in the bone marrow. Lenalidomide has become a critical medicine in modern hematology and oncology treatment protocols worldwide, especially for multiple myeloma patients. Mechanism of Action Lenalidomide works through multiple therapeutic pathways: • Stimulates immune cells to attack cancer cells • Inhibits angiogenesis (formation of tumor blood vessels) • Suppresses abnormal plasma cell growth in bone marrow • Induces apoptosis (programmed death of cancer cells) These combined actions make Lenalidomide one of the most effective targeted immunomodulatory therapies for blood cancers.Medical Uses of Lenalid 15mg Capsule Doctors prescribe Lenalid (Lenalidomide) for several hematologic malignancies: Multiple Myeloma Used in combination with dexamethasone and chemotherapy drugs for treatment of multiple myeloma. Myelodysplastic Syndromes (MDS) Helps treat patients with anemia associated with MDS, particularly those with chromosomal abnormalities. Mantle Cell Lymphoma Used in patients with relapsed or refractory mantle cell lymphoma. Maintenance Therapy Often prescribed after stem cell transplant as maintenance therapy to prevent cancer relapse. Benefits of Lenalid 15mg (Lenalidomide) Capsule • Advanced immunomodulatory anti-cancer therapy • Effective treatment for multiple myeloma • Enhances immune response against malignant cells • Oral capsule therapy for convenient treatment • Recommended in global hematology and oncology treatment guidelines Product Information Product Name: Lenalid Capsule Generic Name: Lenalidomide Strength: 15 mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer/Immunomodulatory Agent Indication: Multiple Myeloma, MDS, Mantle Cell Lymphoma Prescription: Required Global Demand for Lenalidomide Capsules With increasing global cases of multiple myeloma and blood cancers, the demand for Lenalidomide therapy medicines continues to rise worldwide. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Lenalidomide capsules from reliable pharmaceutical exporters in India such as Ernest Oncology. Lenalid 15mg Capsule Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Lenalid 10mg (Lenalidomide) Capsule—Global Supplier & Exporter | Ernest Oncology Lenalid 10mg Lenalidomide Capsules – Advanced Therapy for Multiple Myeloma & Blood Cancers Lenalid 10mg Capsule (Lenalidomide) is an advanced immunomodulatory anti-cancer medicine used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and other hematological malignancies. Lenalidomide works by boosting the immune system and inhibiting the growth of cancer cells. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Lenalid 10mg (Lenalidomide) Capsules to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Lenalid 10mg (Lenalidomide) Capsule? Lenalid 10mg contains Lenalidomide, a potent immunomodulatory drug (IMiD) derived from thalidomide. It helps fight cancer by modifying immune responses and preventing the growth of malignant cells. Lenalidomide therapy has become an essential medicine in modern hematology and oncology treatment protocols, particularly for multiple myeloma patients worldwide. Mechanism of Action Lenalidomide works through multiple mechanisms to combat cancer cells: • Enhances immune system activity against cancer cells • Inhibits angiogenesis (formation of blood vessels supplying tumors) • Suppresses abnormal bone marrow cell growth • Promotes apoptosis (programmed cancer cell death) These actions make Lenalidomide a key therapy in blood cancer treatment strategies. Medical Uses of Lenalid 10mg Capsule Doctors prescribe Lenalid (Lenalidomide) for several hematologic malignancies: Multiple Myeloma Widely used in combination with dexamethasone and other chemotherapy agents for treatment of multiple myeloma. Myelodysplastic Syndromes (MDS) Helps treat patients with transfusion-dependent anemia associated with MDS. Mantle Cell Lymphoma Used for patients with relapsed or refractory mantle cell lymphoma. Post Stem-Cell Transplant Maintenance Lenalidomide is often used as maintenance therapy after stem-cell transplantation in multiple myeloma patients. Benefits of Lenalid 10mg (Lenalidomide) Capsule • Powerful immunomodulatory anti-cancer therapy • Effective for multiple myeloma and blood cancers • Enhances immune system attack on cancer cells • Oral capsule treatment for patient convenience • Recommended in global oncology treatment guidelines Product Information Product Name: Lenalid Capsule Generic Name: Lenalidomide Strength: 10 mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / Immunomodulatory Drug Indication: Multiple Myeloma, MDS, Mantle Cell Lymphoma Prescription: Required Global Demand for Lenalidomide Capsules The global increase in multiple myeloma and hematologic malignancies has significantly increased demand for Lenalidomide therapy medicines. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Lenalidomide capsules from reliable pharmaceutical exporters in India, such as Ernest Oncology. Lenalid 10mg Capsule Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites wwwoncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383 These documents ensure smooth international customs clearance for pharmaceutical shipments.

Ibrunat 140mg (Ibrutinib) Capsule—Global Supplier & Exporter | Ernest Oncology Ibrunat 140mg Ibrutinib Capsules – Targeted Therapy for Leukemia & Lymphoma Ibrunat 140mg Capsule (Ibrutinib) is an advanced targeted anti-cancer medicine used for the treatment of several types of blood cancers including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), Waldenström’s macroglobulinemia, and small lymphocytic lymphoma (SLL). Ibrutinib belongs to a class of medicines called Bruton’s tyrosine kinase (BTK) inhibitors, which block signals that allow cancer cells to grow and survive. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Ibrunat 140mg (Ibrutinib) Capsules to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and international medical procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Ibrunat 140 m (Ibrutinib) Capsule? Ibrunat 140 m contains Ibrutinib, a targeted therapy designed to inhibit Bruton’s Tyrosine Kinase (BTK), an important protein that supports the survival and proliferation of malignant B-cells. By blocking BTK activity, Ibrutinib interferes with cancer cell signaling pathways and helps stop the growth of leukemia and lymphoma cells. Ibrutinib therapy has become an important treatment option in modern hematologic oncology protocols worldwide. Mechanism of Action Ibrutinib works by inhibiting the Bruton’s Tyrosine Kinase (BTK) enzyme, which plays a critical role in B-cell receptor signaling. Its pharmacological actions include: • Blocking BTK-mediated cancer cell signaling • Preventing proliferation of malignant B-cells • Disrupting survival pathways in leukemia and lymphoma cells • Inducing apoptosis (programmed cancer cell death) Through these mechanisms, Ibrutinib helps control the progression of blood cancers and lymphatic malignancies. Medical Uses of Ibrunat 140mg Capsule Doctors prescribe Ibrunat (Ibrutinib) for several hematologic cancer treatments: Chronic Lymphocytic Leukemia (CLL) Used for patients with newly diagnosed or relapsed CLL, including those with high-risk genetic mutations. Mantle Cell Lymphoma (MCL) Effective for mantle cell lymphoma patients who have received prior therapy. Waldenström’s Macroglobulinemia Helps control disease progression in this rare type of lymphoma. Small Lymphocytic Lymphoma (SLL) Used for treatment of SLL, a closely related form of CLL. Benefits of Ibrunat 140mg (Ibrutinib) Capsule • Advanced targeted therapy for blood cancers • Blocks BTK signaling pathways in malignant B-cells • Helps control leukemia and lymphoma progression • Oral capsule therapy for convenient treatment • Recommended in international hematology and oncology guidelines Product Information Product Name: Ibrunat Capsule Generic Name: Ibrutinib Strength: 140 mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / BTK Inhibitor Indication: CLL, MCL, Waldenström’s Macroglobulinemia, SLL Prescription: Required Global Demand for Ibrutinib Capsules The rising global incidence of leukemia and lymphoma has significantly increased demand for Ibrutinib targeted therapy medicines. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Ibrutinib capsules from reliable pharmaceutical exporters in India, such as Ernest Oncology. Ibrunat 140mg Capsule Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries •GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Rybrevant 350mg Injection (Amivantamab) – Global Supplier & Exporter | Ernest Oncology Rybrevant 350mg Injection Rybrevant 350mg Injection contains Amivantamab, a targeted monoclonal antibody therapy used for the treatment of non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations. It belongs to the class of bispecific antibodies that target both EGFR and MET receptors, helping stop cancer cell growth. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Rybrevant 350mg injections to hospitals, oncology centers, pharmaceutical distributors, and international wholesalers worldwide. What is Rybrevant 350mg Injection? Rybrevant is an innovative targeted cancer therapy used to treat adults with advanced or metastatic non-small cell lung cancer (NSCLC) that carries specific genetic mutations. The medicine works by targeting two important pathways involved in cancer cell growth. The active ingredient Amivantamab helps block abnormal signals that promote tumor growth and survival. Mechanism of Action Amivantamab works as a bispecific monoclonal antibody targeting EGFR and MET receptors. Its mechanism includes: • Binding to EGFR and MET receptors on cancer cells • Blocking signals responsible for tumor growth • Activating immune system response against cancer cells • Preventing cancer cell proliferation and survival This dual-target mechanism helps improve treatment effectiveness in certain lung cancers. Indications Rybrevant 350mg Injection is used for the treatment of: • Non-Small Cell Lung Cancer (NSCLC) with EGFR exon 20 insertion mutations • Advanced or metastatic NSCLC in adults • Patients who have progressed after platinum-based chemotherapy Dosage & Administration Typical dosage guidelines: • Administered as intravenous infusion • Initial doses usually given weekly, then every two weeks • Dosage depends on patient body weight Treatment must be administered under the supervision of a qualified oncologist. Key Benefits of Rybrevant 350mg Injection ✔ Advanced bispecific monoclonal antibody therapy ✔ Targets both EGFR and MET pathways ✔ Effective for difficult-to-treat lung cancer mutations ✔ Helps slow tumor growth and progression ✔ Innovative targeted therapy for NSCLC Possible Side Effects Some patients may experience: • Infusion-related reactions • Skin rash • Fatigue • Nausea • Swelling • Breathing difficulties Patients should be monitored carefully during treatment. Product Specifications Product Name: Rybrevant Generic Name: Amivantamab Strength: 350 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Monoclonal Antibody Packaging: Vial Storage: Store in refrigerator (2°C – 8°C) Ernest Oncology supplies Rybrevant 350mg injections worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Scemblix 40mg Tablet (Asciminib) – Global Supplier & Exporter | Ernest Oncology Scemblix 40mg Tablet Scemblix 40mg Tablet contains Asciminib, a targeted anti-cancer medicine used in the treatment of Chronic Myeloid Leukemia (CML) in adults. It belongs to a class of drugs known as STAMP inhibitors (Specifically Targeting the ABL Myristoyl Pocket), designed to block abnormal proteins responsible for leukemia cell growth. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Scemblix 40mg tablets to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What is Scemblix 40mg Tablet? Scemblix 40mg Tablet is a modern targeted therapy for patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). The active ingredient Asciminib works by specifically targeting the ABL kinase protein, which drives the growth of leukemia cells. This advanced therapy offers a new treatment option for patients who have not responded to other tyrosine kinase inhibitor treatments. Mechanism of Action Asciminib works by targeting the ABL myristoyl pocket, a unique mechanism different from traditional tyrosine kinase inhibitors. Its mechanism includes: • Blocking the abnormal BCR-ABL1 protein • Preventing leukemia cell growth and survival • Targeting cancer cells with high specificity • Slowing disease progression in CML patients Indications Scemblix 40mg Tablet is used for the treatment of: • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+ CML) • CML patients previously treated with two or more tyrosine kinase inhibitors • CML with T315I mutation Dosage & Administration Typical dosage guidelines: • 40 mg twice daily or as prescribed by a doctor • Taken without food • Tablets should be swallowed whole with water Treatment should always be taken under the supervision of an oncologist. Key Benefits of Scemblix 40mg Tablet ✔ Advanced STAMP inhibitor targeted therapy ✔ Effective treatment for resistant CML ✔ High specificity for leukemia cells ✔ Helps control disease progression ✔ Innovative mechanism compared to traditional therapies Possible Side Effects Some patients may experience: • Fatigue • Headache • Nausea • Diarrhea • Abdominal pain • Low platelet count Patients should be monitored regularly during treatment. Product Specifications Product Name: Scemblix Generic Name: Asciminib Strength: 40 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / STAMP Inhibitor Packaging: Bottle / Blister Storage: Store below 25°C Ernest Oncology supplies Scemblix 40mg tablets worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Herduo 250mg 30 (Lapatinib) Tablet – Global Supplier & Exporter | Ernest Oncology Herduo 250mg Lapatinib Tablets—Targeted Therapy for HER2-Positive Breast Cancer Herduo 250mg Tablet (Lapatinib) is a highly effective targeted anti-cancer medicine used in the treatment of HER2-positive breast cancer, particularly in patients whose disease has progressed after previous therapies. Lapatinib belongs to a class of medicines called tyrosine kinase inhibitors (TKIs) that block signals responsible for cancer cell growth and tumor progression. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Herduo 250mg (Lapatinib) Tablets to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major international markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Herduo 250mg (Lapatinib) Tablet? Herduo 250mg contains Lapatinib, a targeted therapy designed to block HER2 (Human Epidermal Growth Factor Receptor 2) and EGFR (Epidermal Growth Factor Receptor) signaling pathways that promote cancer cell growth. HER2-positive breast cancer cells produce excessive HER2 protein, leading to aggressive tumor growth. Lapatinib blocks these signals, helping to slow or stop tumor progression. Lapatinib therapy is widely used in advanced breast cancer treatment protocols worldwide. Mechanism of Action Lapatinib works by inhibiting the HER2 and EGFR tyrosine kinase enzymes, which are essential for cancer cell growth. Its pharmacological actions include: • Blocking HER2 receptor signaling • Inhibiting EGFR growth pathways • Preventing cancer cell proliferation • Slowing tumor growth and metastasis Through these mechanisms, Lapatinib helps control HER2-positive breast cancer progression Medical Uses of Herduo 250mg Tablet Doctors prescribe Herduo (Lapatinib) for several breast cancer treatment protocols: HER2-Positive Metastatic Breast Cancer Used for patients with HER2-positive advanced breast cancer. Combination Therapy with Capecitabine Often combined with capecitabine chemotherapy to enhance treatment effectiveness. Hormone-Receptor Positive Breast Cancer Sometimes combined with Letrozole for hormone-receptor-positive and HER2-positive breast cancer. Advanced Breast Cancer Treatment Helps slow disease progression in metastatic cancer patients. Benefits of Herduo 250mg (Lapatinib) Tablet • Advanced targeted therapy for HER2-positive breast cancer • Blocks cancer growth signals from HER2 receptors • Helps slow tumor progression and metastasis • Oral tablet therapy for convenient treatment • Widely recommended in international oncology guidelinesProduct Information Product Name: Herduo Tablet Generic Name: Lapatinib Strength: 250 mg Pack Size: 30 Tablets Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Tyrosine Kinase Inhibitor Indication: HER2-positive advanced or metastatic breast cancer Prescription: Required Global Demand for Lapatinib Tablets The increasing incidence of breast cancer worldwide has significantly increased demand for Lapatinib targeted therapy medicines. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Lapatinib tablets from trusted pharmaceutical exporters in India, such as Ernest Oncology. Herduo 250mg Tablet Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] . 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383.

Nublexa 40mg Tablet (Enzalutamide) – Global Supplier & Exporter | Ernest Oncology Nublexa 40mg Tablet Nublexa 40mg Tablet contains Enzalutamide, a targeted anti-cancer medicine used in the treatment of advanced prostate cancer. This medication belongs to the class of androgen receptor inhibitors, which block the effect of male hormones (androgens) responsible for the growth of prostate cancer cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Nublexa 40mg tablets to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What is Nublexa 40mg Tablet? Nublexa 40mg Tablet is used to treat metastatic and non-metastatic prostate cancer. The medicine works by preventing androgen hormones from binding to receptors on prostate cancer cells, thereby inhibiting cancer growth. This targeted therapy helps slow disease progression and improve survival in prostate cancer patients. Mechanism of Action Enzalutamide works by inhibiting the androgen receptor signaling pathway. Its mechanism includes: • Blocking androgen receptor binding • Preventing activation of androgen receptors • Inhibiting nuclear translocation of androgen receptors • Stopping androgen-driven tumor growth This helps reduce the spread and growth of prostate cancer cells. Indications Nublexa 40mg Tablet is used in the treatment of: • Metastatic Castration-Resistant Prostate Cancer (mCRPC) • Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) It may be used alone or with androgen deprivation therapy. Dosage & Administration Typical dosage guidelines: • 160 mg once daily (4 tablets of 40 mg) • Taken with or without food • Tablets should be swallowed whole with water Treatment must be taken under the supervision of an oncologist. Key Benefits of Nublexa 40mg Tablet ✔ Advanced targeted therapy for prostate cancer ✔ Helps slow tumor growth and disease progression ✔ Improves survival in advanced prostate cancer ✔ Convenient oral tablet treatment ✔ Effective androgen receptor inhibitor therapy Key Benefits of Nublexa 40mg Tablet ✔ Advanced targeted therapy for prostate cancer ✔ Helps slow tumor growth and disease progression ✔ Improves survival in advanced prostate cancer ✔ Convenient oral tablet treatment ✔ Effective androgen receptor inhibitor therapy Product Specifications Product Name: Nublexa Generic Name: Enzalutamide Strength: 40 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Androgen Receptor Inhibitor Packaging: Bottle / Blister Storage: Store below 25°C Ernest Oncology supplies Nublexa 40mg tablets worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Fulvenat 250mg (Fulvestrant) Injection – Global Supplier & Exporter | Ernest Oncology Fulvenat 250mg Fulvestrant Injection – Hormone Therapy for Advanced Breast Cancer Fulvenat 250mg Injection (Fulvestrant) is a widely used hormone therapy medicine prescribed for the treatment of hormone receptor-positive advanced breast cancer in postmenopausal women. Fulvestrant belongs to the class of medicines called selective estrogen receptor degraders (SERDs), which block the action of estrogen that promotes the growth of certain breast cancer cells. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Fulvenat 250mg (Fulvestrant) Injection to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Fulvenat 250mg (Fulvestrant) Injection? Fulvenat 250mg contains Fulvestrant, an anti-estrogen medication used to treat estrogen receptor-positive breast cancer. Unlike some hormone therapies that only block estrogen receptors, Fulvestrant binds to estrogen receptors and causes their degradation, effectively stopping estrogen-driven cancer cell growth. Fulvestrant therapy is widely used in advanced and metastatic breast cancer treatment protocols worldwide. Mechanism of Action Fulvestrant works by binding to estrogen receptors and promoting their degradation, preventing estrogen from stimulating cancer cells. Its pharmacological actions include: • Blocking estrogen receptor signaling • Reducing hormone-dependent tumor growth • Inducing cancer cell apoptosis • Slowing the progression of metastatic breast cancer Because of this targeted hormonal mechanism, Fulvestrant is an important therapy in modern breast cancer treatment. Medical Uses of Fulvenat 250mg Injection Doctors prescribe Fulvenat (Fulvestrant) for several breast cancer treatment protocols: Advanced Breast Cancer Used in postmenopausal women with hormone receptor-positive advanced breast cancer. Metastatic Breast Cancer Helps control disease when breast cancer spreads to other organs. Hormone-Resistant Breast Cancer Used when cancer progresses despite other hormone therapies such as tamoxifen or aromatase inhibitors. Combination Targeted Therapy Often combined with medicines such as: • Palbociclib • Ribociclib • Abemaciclib These combinations improve treatment outcomes in metastatic breast cancer patients. Benefits of Fulvenat 250mg (Fulvestrant) Injection • Advanced hormone therapy for breast cancer • Blocks estrogen receptor signaling • Helps slow tumor growth in metastatic cancer • Effective treatment for hormone-resistant breast cancer • Widely recommended in international oncology guidelines Product Information Product Name: Fulvenat Injection Generic Name: Fulvestrant Strength: 250 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Hormone Therapy (SERD) Indication: Hormone receptor-positive advanced breast cancer Prescription: Required Global Demand for Fulvestrant Injection With the rising global incidence of breast cancer, the demand for Fulvestrant hormone therapy injections continues to grow worldwide. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Fulvestrant injection medicines from trusted pharmaceutical exporters in India such as Ernest Oncology. Fulvestrant 250 Injection Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://

Natzold 5mg Injection (Zoledronic Acid) – Global Supplier & Exporter | Ernest Oncology Natzold 5mg Injection Natzold 5mg Injection contains Zoledronic Acid, a potent bisphosphonate medication used to treat bone complications caused by cancer and osteoporosis. It helps strengthen bones and reduce the risk of fractures in patients with weakened bone structure. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Natzold 5mg injections to hospitals, oncology centers, pharmaceutical distributors, and international wholesalers worldwide. What is Natzold 5mg Injection? Natzold Injection is a medication used to prevent and treat bone loss and bone complications associated with cancer and metabolic bone diseases. The active ingredient Zoledronic Acid works by slowing down bone breakdown and improving bone density. This medicine is commonly used in patients suffering from bone metastases, osteoporosis, and Paget’s disease of bone. Mechanism of Action Zoledronic Acid works by inhibiting osteoclast activity, the cells responsible for bone resorption. Its mechanism includes: • Inhibiting osteoclast-mediated bone breakdown • Strengthening bone density • Reducing risk of fractures • Preventing skeletal complications in cancer patients This helps maintain stronger bones and reduces pain associated with bone diseases. Indications Natzold 5mg Injection is used for the treatment of: • Osteoporosis in postmenopausal women • Osteoporosis in men • Bone metastases from cancer • Paget’s Disease of Bone • Prevention of skeletal-related events in cancer patients Dosage & Administration Typical dosage guidelines: • Administered as intravenous infusion • Usually given once yearly for osteoporosis • In cancer patients dosage may vary depending on condition Treatment should be administered by a healthcare professional under medical supervision. Key Benefits of Natzold 5mg Injection ✔ Helps strengthen bones and improve bone density ✔ Reduces risk of fractures ✔ Prevents bone complications in cancer patients ✔ Long-acting treatment for osteoporosis ✔ Effective bisphosphonate therapy Possible Side Effects Some patients may experience: • Fever or flu-like symptoms • Bone or joint pain • Nausea • Headache • Injection site reactions Patients should be monitored regularly during treatment. Product Specifications Product Name: Natzold Generic Name: Zoledronic Acid Strength: 5 mg Dosage Form: Injection Therapeutic Class: Bisphosphonate / Anti-Resorptive Medicine Packaging: Vial Storage: Store below 25°C Ernest Oncology supplies Natzold 5mg injections worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383